Emergent Biosolutions Inc (EBS)
R&D Expense Growth
-12.38%
Quarterly · Period ending:
EBS R&D Expense Growth
Latest reported-12.38%period ending
Latest reported-12.38%period ending
EBS Quarterly R&D Growth (QoQ) (0.00% → -12.38%)
Latest values, visible window
High-resolution chart · PNG
EBS r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -12.381% | |
| -13.2231% | |
| -10.3704% | |
| 3.8462% | |
| -14.4737% | |
| 67.033% | |
| -34.058% | |
| -57.7982% | |
| 116.5563% | |
| -48.6395% | |
| 92.1569% | |
| -41.1538% | |
| -36.1179% | |
| -13.4043% | |
| 11.3744% | |
| -19.9241% | |
| 13.5776% | |
| -44.0964% | |
| 67.3387% | |
| 1.4315% | |
| -6.8571% | |
| -11.7647% | |
| -29.5024% | |
| 76.2004% | |
| 12.178% | |
| -32.0064% | |
| 17.603% | |
| -16.4319% | |
| 38.6117% | |
| -11.3462% | |
| 40.5405% | |
| 49.7976% | |
| -15.1203% | |
| 2.0551% | |
| 25.8396% | |
| -12.0073% | |
| 25.7619% | |
| -24.4902% | |
| -0.2611% | |
| -2.5275% | |
| 6.8984% | |
| 2.9188% | |
| -25.8229% | |
| 63.13% | |
| -45.8633% | |
| 0.6161% | |
| -13.962% | |
| 19.5342% | |
| 23.6152% | |
| 0.8735% | |
| 3.6528% | |
| -4.429% | |
| -1.4516% | |
| -14.525% | |
| 31.234% | |
| -10.6216% | |
| 16.7606% | |
| -10.655% | |
| 0.5476% | |
| -7.1948% | |
| -9.4307% | |
| 17.3696% | |
| 39.9839% | |
| 13.7297% | |
| -6.6258% | |
| 3.6201% | |
| 2.4185% | |
| -9.2263% | |
| 29.9811% | |
| 12.3429% | |
| -14.8253% | |
| -3.3651% | |
| 49.9434% | |
| -6.4716% | |
| -3.9759% | |
| -4.2347% | |
| -14.3096% | |
| -17.4487% | |
| 112.3986% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 16.129% | |
| 90.7692% | |
| -43.9655% | |
| -19.4444% | |
| 0% |